---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/38288022.md"
description: "$Novo Nordisk AS(NVO.US) This stock currently has no institutional involvement and can be considered abandoned by capital. Retail investors hold over 80%, surpassing Tesla. Currently, trapped positions account for about 70%-90%, with an average cost of $75-83. The stock price decline is not due to heavy short selling but rather low liquidity combined with quantitative trading, resulting in larger fluctuations. The low-level consolidation is expected to persist for another half a year before the trend changes. Currently, it's experiencing a minor rebound in valuation recovery."
datetime: "2026-01-30T15:10:11.000Z"
locales:
  - [en](https://longbridge.com/en/topics/38288022.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/38288022.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/38288022.md)
author: "[爱吃羊肉的耗子](https://longbridge.com/en/profiles/12201248.md)"
---

# $Novo Nordisk AS(NVO.US) This stock currently has …


### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [TSLA.US](https://longbridge.com/en/quote/TSLA.US.md)

## Comments (2)

- **爱吃羊肉的耗子 · 2026-01-30T15:16:52.000Z · 👍 1**: The short-term risk is the approval of Lilly's oral drug in March-April, while in the long run, the market is big enough to grow together with Lilly without one gaining at the expense of the other. The problem is that the earliest time for steady growth is half a year later, and whether you can endu
  - **啊？哥你这是八位数啊** (2026-02-04T12:28:02.000Z): Can't stand it. Should put the money elsewhere to improve utilization.